Αρχική World News Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Prolongs OS Among Patients... World News Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Prolongs OS Among Patients with Early-Stage TNBC Από Ogkologos - 8 Νοεμβρίου, 2024 747 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KEYNOTE-522 study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR “No Person With Cancer or Survivor Should Ever Feel Alone”: A... 2 Ιουνίου, 2021 FDA Approves Axicabtagene Ciloleucel for Second-Line Treatment of Large B-Cell Lymphoma 27 Απριλίου, 2022 6-Year-Old Uses Money From Lemonade Stand To Take Mom Out On... 6 Αυγούστου, 2019 Adding Capivasertib to Fulvestrant Results in Longer PFS in Patients with... 5 Ιουνίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Progression-Free Survival and Overall Survival Significantly Longer with Lenvatinib Plus Pembrolizumab... Spotlight On: Exercise Physiologists in Cancer Care We want every scientist to thrive in cancer research Implanted “Drug Factories” Deliver Cancer Treatment Directly to Tumors
